Corcept targets $3B-$5B in Cushing’s revenue in 2030 as it awaits December 17 relacorilant FDA decision
Source: Seeking Alpha ·
Read the full story at Seeking Alpha
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.